Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis
Sema Dündar, Mimbay Yaşar, Harun Çakmak, Nefati Kıylıoğlu, Alparslan Ünsal · 2023
Read Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis by Sema Dündar, Mimbay Yaşar, Harun Çakmak, Nefati Kıylıoğlu, Alparslan Ünsal (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10726561.txt.
Description
Sema Dündar and co-authors report a rare drug side effect in a 2023 case study. A 58-year-old woman came in with two days of blurred vision in her right eye while taking infliximab, an immune-calming antibody, for ankylosing spondylitis.
Her right eye could barely count fingers, yet the back of the eye looked healthy, a pattern pointing behind the eyeball. A scan showed a bright signal in the right optic nerve, fitting retrobulbar optic neuritis. Doctors stopped the infliximab and started steroids, and her vision returned to full strength. The authors remind clinicians that this vision threat, though rare, belongs on the watch list for any patient on the drug.
Catalog record
| CREATOR | Sema Dündar, Mimbay Yaşar, Harun Çakmak, Nefati Kıylıoğlu, Alparslan Ünsal |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |